DNDi aims to:

  • Deliver a safe, effective, affordable, and field-adapted drug that can kill adult filarial worms (a ‘macrofi laricide’) and be used for prevention or individual treatment.

 

The current filarial diseases portfolio includes:

Translation

Translation

Emodepside
Macrofilaricide CC6166
Oxfendazole
TylAMac (ABBV-4083)

 

For more details on each project, see DNDi‘s Global Portfolio